The ABVD regimen is a combination chemotherapy treatment used primarily for Hodgkin Lymphoma. It consists of four drugs: Adriamycin (doxorubicin), Bleomycin, Vinblastine, and Dacarbazine. This regimen is designed to target and kill rapidly dividing cancer cells, thereby reducing the size of tumors and eliminating cancer from the body.
